Bulk Manufacturer of Controlled Substances Application: Johnson Matthey Pharmaceutical Materials Inc., 74765 [2020-25764]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 226 / Monday, November 23, 2020 / Notices
Register pursuant to Section 6(b) of the
Act on November 12, 2019 (84 FR
61071).
The last notification was filed with
the Department on July 7, 2020. A
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on July 31, 2020 (85 FR 46179).
Suzanne Morris,
Chief, Premerger and Division Statistics,
Antitrust Division.
[FR Doc. 2020–25745 Filed 11–20–20; 8:45 am]
BILLING CODE 4410–11–P
DEPARTMENT OF JUSTICE
Controlled substance
Remifentanil ..............................
Sufentanil ..................................
Drug
code
Schedule
9739
9740
II
II
The company plans to support its
other manufacturing facilities located in
West Deptford, New Jersey and
Conshohocken, Pennsylvania with
manufacturing and analytical testing.
In reference to drug code 9333 as
bulk, the company plans to manufacture
a Thebaine derivative for distribution to
its customers. No other activity for these
drug codes is authorized for this
registration.
Drug Enforcement Administration
William T. McDermott,
Assistant Administrator.
[Docket No. DEA–745]
[FR Doc. 2020–25764 Filed 11–20–20; 8:45 am]
Bulk Manufacturer of Controlled
Substances Application: Johnson
Matthey Pharmaceutical Materials Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Johnson Matthey
Pharmaceutical Materials Inc. has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTAL INFORMATION listed below
for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before January 22, 2021. Such
persons may also file a written request
for a hearing on the application on or
before January 22, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on November 2, 2020,
Johnson Matthey Pharmaceutical
Materials Inc., 25 Patton Road, Devens,
Massachusetts 01434, applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substance(s):
Drug
code
Schedule
1100
1724
7379
9193
9220
9333
9737
II
II
II
II
II
II
II
Amphetamine ............................
Methylphenidate ........................
Nabilone ....................................
Hydrocodone .............................
Levorphanol ..............................
Thebaine ...................................
Alfentanil ...................................
VerDate Sep<11>2014
19:39 Nov 20, 2020
OCCUPATIONAL SAFETY AND
HEALTH ADMINISTRATION
[Docket No. OSHA–2011–0028]
SUMMARY:
Controlled substance
BILLING CODE P
Jkt 253001
Grain Handling Facilities; Extension of
the Office of Management and
Budget’s (OMB) Approval of
Information Collection (Paperwork)
Requirements
Occupational Safety and Health
Administration (OSHA), Labor.
ACTION: Request for public comments.
AGENCY:
OSHA solicits public
comments concerning the proposal to
extend the Office of Management and
Budget’s (OMB) approval of the
information collection requirements
contained in the standard on Grain
Handling Facilities.
DATES: Comments must be submitted
(postmarked, sent, or received) by
January 22, 2021.
ADDRESSES:
Electronically: You may submit
comments and attachments
electronically at https://
www.regulations,gov, which is the
Federal eRulemaking Portal. Follow the
instructions online for submitting
comments.
Facsimile: If your comments,
including attachments, are not longer
than 10 pages you may fax them to the
OSHA Docket Office at (202) 693–1648.
Mail, hand delivery, express mail,
messenger, or courier service: When
using this method, you must submit a
copy of your comments and attachments
to the OSHA Docket Office, OSHA
Docket No. OSHA–2011–0028,
Occupational Safety and Health
Administration, U.S. Department of
Labor, Room N–3653, 200 Constitution
SUMMARY:
PO 00000
Frm 00102
Fmt 4703
Sfmt 4703
74765
Avenue NW, Washington, DC 20210.
Please note: While OSHA’s Docket
Office is continuing to accept and
process submissions by regular mail,
due to the COVID–19 pandemic, the
Docket Office is closed to the public and
not able to received submissions to the
docket by hand, express mail,
messenger, and courier service.
Instructions: All submissions must
include the agency name and the OSHA
docket number (OSHA–2011–0028) for
the Information Collection Request
(ICR). All comments, including any
personal information you provide, such
as social security numbers and date of
birth, are placed in the public docket
without change, and may be made
available online at https://
www.regulations.gov. For further
information on submitting comments
see the ‘‘Public Participation’’ heading
in the section of this notice titled
SUPPLEMENTARY INFORMATION.
Docket: To read or download
comments or other material in the
docket, go to https://www.regulations.gov
or the OSHA Docket Office at the above
address. All documents in the docket
(including this Federal Register notice)
are listed in the https://
www.regulations.gov index; however,
some information (e.g., copyrighted
material) is not publicly available to
read or download through the website.
All submissions, including copyrighted
material, are available for inspection
and copying at the OSHA Docket Office.
You may also contact Theda Kenney at
the below phone number to obtain a
copy of the ICR.
FOR FURTHER INFORMATION CONTACT:
Seleda Perryman or Theda Kenney,
Directorate of Standards and Guidance,
OSHA, U.S. Department of Labor;
telephone (202) 693–2222.
SUPPLEMENTARY INFORMATION:
I. Background
The Department of Labor, as part of
the continuing effort to reduce
paperwork and respondent (i.e.,
employer) burden, conducts a
preclearance consultation program to
provide the public with an opportunity
to comment on proposed and
continuing information collection
requirements in accordance with the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3506(c)(2)(A)). This program
ensures that information is in the
desired format, reporting burden (time
and costs) is minimal, collection
instruments are clearly understood, and
OSHA’s estimate of the information
collection burden is accurate. The
Occupational Safety and Health Act of
1970 (OSH Act) (29 U.S.C. 651 et seq.)
E:\FR\FM\23NON1.SGM
23NON1
]]>Agencies
[Federal Register Volume 85, Number 226 (Monday, November 23, 2020)]
[Notices]
[Page 74765]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-25764]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-745]
Bulk Manufacturer of Controlled Substances Application: Johnson
Matthey Pharmaceutical Materials Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Johnson Matthey Pharmaceutical Materials Inc. has applied to
be registered as a bulk manufacturer of basic class(es) of controlled
substance(s). Refer to Supplemental Information listed below for
further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before January 22,
2021. Such persons may also file a written request for a hearing on the
application on or before January 22, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on November 2, 2020, Johnson Matthey Pharmaceutical
Materials Inc., 25 Patton Road, Devens, Massachusetts 01434, applied to
be registered as a bulk manufacturer of the following basic class(es)
of controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Amphetamine............................. 1100 II
Methylphenidate......................... 1724 II
Nabilone................................ 7379 II
Hydrocodone............................. 9193 II
Levorphanol............................. 9220 II
Thebaine................................ 9333 II
Alfentanil.............................. 9737 II
Remifentanil............................ 9739 II
Sufentanil.............................. 9740 II
------------------------------------------------------------------------
The company plans to support its other manufacturing facilities
located in West Deptford, New Jersey and Conshohocken, Pennsylvania
with manufacturing and analytical testing.
In reference to drug code 9333 as bulk, the company plans to
manufacture a Thebaine derivative for distribution to its customers. No
other activity for these drug codes is authorized for this
registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-25764 Filed 11-20-20; 8:45 am]
BILLING CODE P
